SCHROEDER THILO sold 4.8% of their position (96.14K shares) of PMV PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $3.37M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−13.03K
Price / share
$34.74
Trade value
$452.70K
% of position
Common Stock
Shares
−30.14K
Price / share
$33.80
Trade value
$1.02M
% of position
Common Stock
Shares
−100.00
Price / share
$34.74
Trade value
$3.47K
% of position
Common Stock
Shares
−1.76K
Price / share
$34.21
Trade value
$60.21K
% of position
Common Stock
Shares
−17.18K
Price / share
$35.10
Trade value
$602.84K
% of position
Common Stock
Shares
−28.68K
Price / share
$36.22
Trade value
$1.04M
% of position
Common Stock
Shares
−5.25K
Price / share
$36.80
Trade value
$193.16K
% of position
Net shares
−96.14K
Net value
-$3.37M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/2/2021 | S · Sale | −13.03K | $34.74 | $452.70K | 0.7% | 1.99M | 1.98M |
| Common Stock Indirect | 8/3/2021 | S · Sale | −30.14K | $33.80 | $1.02M | 1.5% | 1.98M | 1.95M |
| Common Stock Indirect | 8/3/2021 | S · Sale | −100.00 | $34.74 | $3.47K | 0.0% | 1.95M | 1.95M |
| Common Stock Indirect | 8/4/2021 | S · Sale | −1.76K | $34.21 | $60.21K | 0.1% | 1.95M | 1.95M |
| Common Stock Indirect | 8/4/2021 | S · Sale | −17.18K | $35.10 | $602.84K | 0.9% | 1.95M | 1.93M |
| Common Stock Indirect | 8/4/2021 | S · Sale | −28.68K | $36.22 | $1.04M | 1.5% | 1.93M | 1.90M |
| Common Stock Indirect | 8/4/2021 | S · Sale | −5.25K | $36.80 | $193.16K | 0.3% | 1.90M | 1.90M |
| Total | −96.14K | -$3.37M | ||||||